share_log

Ayala Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.B.F Management Ltd.(71.63%),Israel Biotech Fund II, L.P.(44.79%), etc.

SEC ·  Feb 13, 2024 01:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more